• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内分泌、激素和泌尿科药物的术前管理:围手术期评估和质量改进协会(SPAQI)共识声明。

Preoperative Management of Endocrine, Hormonal, and Urologic Medications: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement.

机构信息

Department of Medicine, Medical College of Wisconsin, Milwaukee.

Department of Anesthesiology, University of Colorado School of Medicine, Aurora.

出版信息

Mayo Clin Proc. 2021 Jun;96(6):1655-1669. doi: 10.1016/j.mayocp.2020.10.002. Epub 2021 Mar 10.

DOI:10.1016/j.mayocp.2020.10.002
PMID:33714600
Abstract

Perioperative medical management is challenging due to the rising complexity of patients presenting for surgical procedures. A key part of preoperative optimization is appropriate management of long-term medications, yet guidelines and consensus statements for perioperative medication management are lacking. Available resources utilize the recommendations derived from individual studies and do not include a multidisciplinary focus or formal consensus. The Society for Perioperative Assessment and Quality Improvement (SPAQI) identified a lack of authoritative clinical guidance as an opportunity to utilize its multidisciplinary membership to improve evidence-based perioperative care. SPAQI seeks to provide guidance on perioperative medication management that synthesizes available literature with expert consensus. The aim of this Consensus Statement is to provide practical guidance on the preoperative management of endocrine, hormonal, and urologic medications. A panel of experts with anesthesiology, perioperative medicine, hospital medicine, general internal medicine, and medical specialty experience was drawn together and identified the common medications in each of these categories. The authors then utilized a modified Delphi approach to critically review the literature and generate consensus recommendations.

摘要

由于接受手术的患者的复杂性不断增加,围手术期的医疗管理极具挑战性。术前优化的一个关键部分是对长期药物进行适当管理,但围手术期药物管理的指南和共识声明却缺乏。现有的资源利用了从个别研究中得出的建议,并未包括多学科重点或正式共识。围手术期评估和质量改进协会 (SPAQI) 发现,缺乏权威性的临床指导是一个机会,可以利用其多学科成员来改善基于证据的围手术期护理。SPAQI 旨在提供围手术期药物管理方面的指导,将现有文献与专家共识相结合。本共识声明旨在就内分泌、激素和泌尿科药物的术前管理提供实用指南。一个汇集了麻醉学、围手术期医学、医院医学、普通内科和医学专业经验的专家小组被召集在一起,并确定了这些类别中的常见药物。然后,作者使用改良 Delphi 方法对文献进行严格审查,并提出共识建议。

相似文献

1
Preoperative Management of Endocrine, Hormonal, and Urologic Medications: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement.内分泌、激素和泌尿科药物的术前管理:围手术期评估和质量改进协会(SPAQI)共识声明。
Mayo Clin Proc. 2021 Jun;96(6):1655-1669. doi: 10.1016/j.mayocp.2020.10.002. Epub 2021 Mar 10.
2
Preoperative Management of Medications for Rheumatologic and HIV Diseases: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement.风湿免疫和 HIV 疾病患者围手术期药物管理:围手术期评估和质量改进学会(SPAQI)共识声明。
Mayo Clin Proc. 2022 Aug;97(8):1551-1571. doi: 10.1016/j.mayocp.2022.05.002.
3
Preoperative Management of Gastrointestinal and Pulmonary Medications: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement.胃肠道和肺部药物的术前管理:围手术期评估和质量改进协会(SPAQI)共识声明。
Mayo Clin Proc. 2021 Dec;96(12):3158-3177. doi: 10.1016/j.mayocp.2021.08.008. Epub 2021 Nov 2.
4
Preoperative Management of Opioid and Nonopioid Analgesics: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement.术前阿片类和非阿片类镇痛药管理:围手术期评估和质量改进协会(SPAQI)共识声明。
Mayo Clin Proc. 2021 May;96(5):1325-1341. doi: 10.1016/j.mayocp.2020.06.045. Epub 2021 Feb 19.
5
Preoperative Management of Surgical Patients Using Dietary Supplements: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement.手术患者术前使用膳食补充剂的管理:围手术期评估和质量改进协会(SPAQI)共识声明。
Mayo Clin Proc. 2021 May;96(5):1342-1355. doi: 10.1016/j.mayocp.2020.08.016. Epub 2021 Mar 16.
6
Preoperative Management of Cardiovascular Medications: A Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement.心血管药物的术前管理:围手术期评估和质量改进协会(SPAQI)共识声明。
Mayo Clin Proc. 2022 Sep;97(9):1734-1751. doi: 10.1016/j.mayocp.2022.03.039.
7
Preoperative Management of Medications for Psychiatric Diseases: Society for Perioperative Assessment and Quality Improvement Consensus Statement.术前精神疾病药物管理:围手术期评估和质量改进学会共识声明。
Mayo Clin Proc. 2022 Feb;97(2):397-416. doi: 10.1016/j.mayocp.2021.11.011.
8
Striving for Evidence-Based, Patient-Centered Guidance: The Impetus Behind the Society for Perioperative Assessment and Quality Improvement (SPAQI) Medication Management Consensus Statements.追求基于证据、以患者为中心的指导:围手术期评估与质量改进协会(SPAQI)药物管理共识声明背后的推动力。
Mayo Clin Proc. 2021 May;96(5):1117-1119. doi: 10.1016/j.mayocp.2020.06.022. Epub 2021 Feb 19.
9
Preoperative Management of Medications for Neurologic Diseases: Society for Perioperative Assessment and Quality Improvement Consensus Statement.神经疾病相关药物的术前管理:围手术期评估和质量改进学会共识声明。
Mayo Clin Proc. 2022 Feb;97(2):375-396. doi: 10.1016/j.mayocp.2021.11.010.
10
Society for Ambulatory Anesthesia Updated Consensus Statement on Perioperative Blood Glucose Management in Adult Patients With Diabetes Mellitus Undergoing Ambulatory Surgery.美国门诊麻醉学会关于成人糖尿病患者在门诊手术期间血糖管理的最新共识声明。
Anesth Analg. 2024 Sep 1;139(3):459-477. doi: 10.1213/ANE.0000000000006791. Epub 2024 Mar 22.

引用本文的文献

1
Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons.胰高血糖素样肽-1受体激动剂的获益-风险评估:对皮肤科医生和整形外科医生的启示
Dermatol Ther (Heidelb). 2025 Sep 9. doi: 10.1007/s13555-025-01537-5.
2
Online Information About Side Effects and Safety Concerns of Semaglutide: Mixed Methods Study of YouTube Videos.司美格鲁肽副作用及安全性问题的在线信息:YouTube视频的混合方法研究
JMIR Infodemiology. 2025 Apr 8;5:e59767. doi: 10.2196/59767.
3
Comparing the risk of gastroparesis following different modalities for treating obesity: semaglutide versus bupropion-naltrexone versus sleeve gastrectomy - a retrospective cohort study.
比较不同肥胖治疗方式后发生胃轻瘫的风险:司美格鲁肽与安非他酮-纳曲酮与袖状胃切除术——一项回顾性队列研究。
BMJ Open Gastroenterol. 2025 Apr 2;12(1):e001704. doi: 10.1136/bmjgast-2024-001704.
4
Preoperative medication management turnkey order set for nonemergent adult cardiac surgery.非急诊成人心脏手术术前用药管理一站式医嘱集
JTCVS Open. 2024 Jun 25;22:1-13. doi: 10.1016/j.xjon.2024.06.009. eCollection 2024 Dec.
5
A Scoping Review of GLP-1 Receptor Agonists: Are They Associated with Increased Gastric Contents, Regurgitation, and Aspiration Events?胰高血糖素样肽-1受体激动剂的范围综述:它们是否与胃内容物增加、反流和误吸事件有关?
J Clin Med. 2024 Oct 23;13(21):6336. doi: 10.3390/jcm13216336.
6
Comparison of societal guidance on perioperative management of glucagon-like peptide-1 receptor agonists: implications for clinical practice and future investigations.比较胰高血糖素样肽-1 受体激动剂围手术期管理的社会指导:对临床实践和未来研究的影响。
Can J Anaesth. 2024 Sep;71(9):1302-1315. doi: 10.1007/s12630-024-02810-5. Epub 2024 Aug 26.
7
Role of incretins and glucagon receptor agonists in metabolic dysfunction-associated steatotic liver disease: Opportunities and challenges.肠促胰岛素和胰高血糖素受体激动剂在代谢功能障碍相关脂肪性肝病中的作用:机遇与挑战
World J Hepatol. 2024 May 27;16(5):731-750. doi: 10.4254/wjh.v16.i5.731.
8
Feminizing Gender Affirming Breast Surgery: Procedural Outcomes at a Single Academic Institution.女性化性别确认乳房手术:单一学术机构的手术结果
Aesthet Surg J Open Forum. 2024 Apr 28;6:ojae032. doi: 10.1093/asjof/ojae032. eCollection 2024.
9
Glucagon-like peptide-1 receptor agonists in the perioperative period: Implications for the anaesthesiologist.围手术期胰高血糖素样肽-1受体激动剂:对麻醉医生的启示
Eur J Anaesthesiol. 2024 Mar 1;41(3):245-246. doi: 10.1097/EJA.0000000000001914. Epub 2024 Feb 2.
10
Editorial: New Trends and Approaches in Perioperative Pharmacotherapy: An Update.社论:围手术期药物治疗的新趋势与新方法:最新进展
Front Pharmacol. 2021 Aug 6;12:721075. doi: 10.3389/fphar.2021.721075. eCollection 2021.